Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use

[1]  C. Baudouin,et al.  A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. , 2017, Investigative ophthalmology & visual science.

[2]  I. Kozák,et al.  Efficacy of topical cysteamine in nephropathic cystinosis , 2017, British Journal of Ophthalmology.

[3]  J. Jester,et al.  Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis. , 2016, Molecular pharmaceutics.

[4]  B. Radojković Cysteamine eye drops in the treatment of cystinosis – an Australian perspective , 2015 .

[5]  K. Ramaesh,et al.  Treatment of corneal cystine crystal accumulation in patients with cystinosis , 2014, Clinical ophthalmology.

[6]  G. Deschênes,et al.  A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. , 2014, Molecular genetics and metabolism.

[7]  W. Gahl,et al.  Cystinosis: the evolution of a treatable disease , 2012, Pediatric Nephrology.

[8]  J. Jester,et al.  Evaluation of topical cysteamine therapy in the CTNS−/− knockout mouse using in vivo confocal microscopy , 2011, Molecular vision.

[9]  N. Soliman,et al.  Nephropathic cystinosis in children: An overlooked disease. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[10]  Robert Kleta,et al.  Pharmacological treatment of nephropathic cystinosis with cysteamine , 2004, Expert opinion on pharmacotherapy.

[11]  W. Gahl,et al.  Long-term follow-up of well-treated nephropathic cystinosis patients. , 2004, The Journal of pediatrics.

[12]  W. Gahl Early oral cysteamine therapy for nephropathic cystinosis , 2003, European Journal of Pediatrics.

[13]  M. Kaiser-Kupfer,et al.  A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis , 2003, The British journal of ophthalmology.

[14]  E. Kuehl,et al.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.

[15]  E. Kuehl,et al.  A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. , 1998, Molecular genetics and metabolism.

[16]  M. Spencer,et al.  A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis , 1991, Eye.

[17]  E. Kuehl,et al.  A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. , 1990, Archives of ophthalmology.

[18]  M. Kaiser-Kupfer,et al.  Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. , 1987, The New England journal of medicine.

[19]  W. Gahl,et al.  Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. , 1985, The Biochemical journal.

[20]  R. Pisoni,et al.  Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal? , 1985, The Journal of biological chemistry.